Rotateq vaccine 2ML
Ended Awarded
- Contract number
- SPE2DB25FN3NQ
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $4,150
Award facts
- Contract value 100% obligated
- $4,150.39 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a $4,150.39 delivery order to AmerisourceBergen Drug Corp for RotaTeq vaccine (2 mL) on August 1, 2025, with an ultimate completion date of August 4, 2025. The contract utilizes firm fixed price pricing and carries no set-aside designation, indicating it was competitively awarded. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and running through December 2026.
AmerisourceBergen Drug Corp serves as a critical pharmaceutical and healthcare solutions provider within the federal medical procurement system, with extensive experience supplying vaccines, medications, and medical supplies to military and veteran healthcare systems. RotaTeq is a rotavirus vaccine commonly used in pediatric immunization programs supported by military healthcare and federal medical systems. The company's significant IDC with DLA enables flexible fulfillment of diverse pharmaceutical and vaccine requirements across federal agencies, including the Defense Health Agency and U.S. Coast Guard, positioning it as a primary vendor for comprehensive global pharmaceutical support to military healthcare programs.
Quick answers
Who was awarded contract SPE2DB25FN3NQ?
SPE2DB25FN3NQ was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 1, 2025.
How much is contract SPE2DB25FN3NQ worth?
The government has obligated $4,150 on SPE2DB25FN3NQ.
Is contract SPE2DB25FN3NQ an order under another contract?
Yes. SPE2DB25FN3NQ is a delivery order under SPE2DB22D1200, an indefinite delivery contract.
Was contract SPE2DB25FN3NQ competed?
The extent of competition for SPE2DB25FN3NQ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award